Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (PACTR202609768716927) titled 'A Phase III study to investigate the efficacy and safety of elecoglipron alone or in combination with dapagliflozin compared with placebo in adults with type 2 diabetes mellitus' on Sept. 11.
Study Type: Interventional
Study Design:
Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomization using a randomization table created by a computer software program,Central randomisation by phone/fax
Primary Sponsor: AstraZeneca AB
Condition:
Nutritional, Metabolic, Endocrine
Nutritional, Metabolic, Endocrine
Intervention:
Elecoglipron
Elecoglipron
Eleco...